IL140415A0 - The use of valproic acid analog for the treatment and prevention of migraine and affective illness - Google Patents

The use of valproic acid analog for the treatment and prevention of migraine and affective illness

Info

Publication number
IL140415A0
IL140415A0 IL14041599A IL14041599A IL140415A0 IL 140415 A0 IL140415 A0 IL 140415A0 IL 14041599 A IL14041599 A IL 14041599A IL 14041599 A IL14041599 A IL 14041599A IL 140415 A0 IL140415 A0 IL 140415A0
Authority
IL
Israel
Prior art keywords
migraine
prevention
treatment
valproic acid
acid analog
Prior art date
Application number
IL14041599A
Other languages
English (en)
Original Assignee
American Biogenetic Sciences
Heinz Nau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Biogenetic Sciences, Heinz Nau filed Critical American Biogenetic Sciences
Publication of IL140415A0 publication Critical patent/IL140415A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14041599A 1998-06-22 1999-06-22 The use of valproic acid analog for the treatment and prevention of migraine and affective illness IL140415A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9028198P 1998-06-22 1998-06-22
PCT/US1999/014081 WO1999066920A1 (en) 1998-06-22 1999-06-22 The use of valproic acid analog for the treatment and prevention of migraine and affective illness

Publications (1)

Publication Number Publication Date
IL140415A0 true IL140415A0 (en) 2002-02-10

Family

ID=22222101

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14041599A IL140415A0 (en) 1998-06-22 1999-06-22 The use of valproic acid analog for the treatment and prevention of migraine and affective illness

Country Status (19)

Country Link
US (2) US6268396B1 (xx)
EP (1) EP1089725A1 (xx)
JP (1) JP2002518442A (xx)
KR (1) KR20010071572A (xx)
CN (1) CN1310622A (xx)
AU (2) AU752192B2 (xx)
BG (1) BG63744B1 (xx)
BR (1) BR9911421A (xx)
CA (1) CA2335641A1 (xx)
CZ (1) CZ20004833A3 (xx)
HU (1) HUP0102456A3 (xx)
IL (1) IL140415A0 (xx)
MX (1) MXPA00012808A (xx)
NO (1) NO20006506L (xx)
PL (1) PL345364A1 (xx)
SK (1) SK19992000A3 (xx)
TR (2) TR200003800T2 (xx)
WO (1) WO1999066920A1 (xx)
ZA (1) ZA200007652B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6104802A (en) 1997-02-10 2000-08-15 Genesys Telecommunications Laboratories, Inc. In-band signaling for routing
WO2000066109A2 (en) * 1999-05-04 2000-11-09 Edwards Keith R Intravenous valproate for acute treatment of migraine headache
NZ523917A (en) * 2000-07-21 2004-11-26 Teva Pharma Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
AU8830801A (en) * 2000-08-17 2002-02-25 Teva Pharma Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
US20020103110A1 (en) * 2001-01-26 2002-08-01 Spitzer A. Robert System and method for rectal administration of medication for treatment of migraines
US7968569B2 (en) * 2002-05-17 2011-06-28 Celgene Corporation Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
EP1562975A2 (en) * 2002-10-25 2005-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
US20060166894A1 (en) * 2002-11-29 2006-07-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
US20060223888A1 (en) * 2002-12-16 2006-10-05 Abbott Frank S Valproic acid analogues and pharmaceutical composition thereof
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
WO2006012603A2 (en) * 2004-07-22 2006-02-02 Nps Pharmaceuticals, Inc. Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases
US20080234213A1 (en) * 2005-09-02 2008-09-25 Matthias Wabl Oncogenic regulatory RNAs for diagnostics and therapeutics
US7459280B2 (en) * 2006-02-27 2008-12-02 Picobella, Llc Methods for diagnosing and treating kidney cancer
US20080267977A1 (en) * 2007-04-26 2008-10-30 Friedrich-Alexander University Of Erlangen-Nuremberg Combined immunological agent and sensitizing agent for the treatment of cancer
CN104797568A (zh) * 2012-05-08 2015-07-22 塞利克斯比奥私人有限公司 用于治疗神经障碍的组合物和方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2442M (fr) 1962-10-17 1964-04-06 Henry Eugene L'acide dipropylacétique et ses dérivés en tant que nouveuax médicaments dépresseurs du systeme nerveux central.
US3701729A (en) 1970-06-01 1972-10-31 Tenneco Chem Oil-soluble mixed copper soap products
US3847956A (en) 1973-04-06 1974-11-12 Us Agriculture 2-hydroperoxycarboxylic acids and their preparation
US3932285A (en) 1973-10-03 1976-01-13 Tenneco Chemicals, Inc. Chromium salt compositions and a process for their production
US4025649A (en) 1974-08-19 1977-05-24 Labaz Acetic acid derivatives having pharmacological activity and compositions containing the same
US4129599A (en) 1975-04-28 1978-12-12 The Board Of Trustees Of Leland Stanford Jr. University A-Norsteroids
JPS5680116A (en) 1979-12-05 1981-07-01 Sanyo Electric Co Ltd Manufacture of substrate for magnetic bubble
JPH0233704B2 (ja) 1982-10-07 1990-07-30 Takeda Chemical Industries Ltd Chikanbinirukarubonsanjudotai
FR2599737B1 (fr) 1986-06-10 1989-05-19 Sanofi Sa Procede pour la fixation de groupes alkyles, alkenyles, cycloalkyles ou aralkyles sur une chaine carbonee portant un groupement fonctionnel
JPH01135740A (ja) 1987-11-24 1989-05-29 Nippon Mining Co Ltd 光学活性を有する２―アルキル―１―アルカン酸の製造方法
US5021398A (en) 1989-10-26 1991-06-04 Amp Incorporated Method of forming patterned oxide superconducting films
US5102913A (en) * 1991-07-01 1992-04-07 Halikas James A Treatment for cocaine use employing valproic acid
DE4231085A1 (de) * 1992-09-12 1994-03-17 Desitin Arzneimittel Gmbh VPA-analoge Antiepileptika
DE69310525T2 (de) 1992-09-16 1997-10-02 Genentech Inc Schutz gegen leberschäden mit hgf
JPH08503732A (ja) 1992-11-30 1996-04-23 ザ、プロクター、エンド、ギャンブル、カンパニー 特選の石鹸を含有する高起泡性洗剤組成物
JP3304459B2 (ja) 1992-12-18 2002-07-22 松下電器産業株式会社 電解コンデンサ駆動用電解液およびそれを用いた電解コンデンサ
EP0632008B1 (en) 1993-06-01 1998-02-04 Ono Pharmaceutical Co., Ltd. Pentanoic acid derivatives
US5503830A (en) 1993-09-10 1996-04-02 Petrovax, L.L.C. Compounds having immunostimulating activity and methods of use thereof
WO1995033044A1 (en) 1994-05-27 1995-12-07 The Procter & Gamble Company Liquid laundry detergent compositions comprising specially selected soaps
US5681854A (en) 1995-11-22 1997-10-28 Alcon Laboratories, Inc. Use of aliphatic carboxylic acid derivatives in ophthalmic disorders
IT1283489B1 (it) 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico

Also Published As

Publication number Publication date
TR200103249T2 (tr) 2002-05-21
WO1999066920A1 (en) 1999-12-29
KR20010071572A (ko) 2001-07-28
US20010031789A1 (en) 2001-10-18
AU752192B2 (en) 2002-09-12
PL345364A1 (en) 2001-12-17
AU5207199A (en) 2000-01-24
NO20006506D0 (no) 2000-12-20
SK19992000A3 (sk) 2001-08-06
CA2335641A1 (en) 1999-12-29
AU4707199A (en) 2000-01-10
US6268396B1 (en) 2001-07-31
BG63744B1 (bg) 2002-11-29
US6458840B2 (en) 2002-10-01
TR200003800T2 (tr) 2001-06-21
MXPA00012808A (es) 2002-04-24
CZ20004833A3 (cs) 2002-01-16
BG105163A (en) 2002-03-29
HUP0102456A3 (en) 2003-07-28
NO20006506L (no) 2001-02-21
BR9911421A (pt) 2001-03-27
JP2002518442A (ja) 2002-06-25
ZA200007652B (en) 2002-03-19
EP1089725A1 (en) 2001-04-11
HUP0102456A2 (hu) 2001-10-28
CN1310622A (zh) 2001-08-29

Similar Documents

Publication Publication Date Title
IL187030A0 (en) Use of retigabine for the treatment of neuropathic pain
HUP0104425A3 (en) Anthranilic acid amides and the use thereof for the treatment of angiogenesis
HUP9774641A2 (en) Gel for treatment of skin diseases and for disinfection of the skin
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
HK1048949A1 (en) Method and composition for the treatment of scars
HK1000697A1 (en) Use of droloxifene for the treatment of cardiovascular diseases
PL345364A1 (en) The use of valproic acid analog for the treatment and prevention of migraine and affective illness
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU2463099A (en) Gabapentin and its derivatives for the treatment of muscular and skeletal pain
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
AU8588898A (en) Composition and process for the treatment of epidermal traumas such as decubitusulcers
GB9808936D0 (en) Combination therapy for the prevention and treatment of osteoporosis
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
AP2002002483A0 (en) Lactic acid bacteria for the treatment and/or prophylaxix of giardasis
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
EP1189584A4 (en) CARE AND DERMATOLOGICAL COMPOSITION BASED ON ALPHA-AMINO ACID
HUP0200005A3 (en) Composition for the treatment of psoriasis and process for its preparation
IL125660A0 (en) Pharmaceutical composition comprising 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the aminobenzoic acid for the treatment or prevention of restenosis and its manufacture
HUP0300043A3 (en) Method and composition for the treatment of pain
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections